NCT06571045 · Interventional trial
A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions Diabetic Macular Edema (DME)
Delaware Valley sites
- Cherry Hill, NJ · Cherry Hill, NJ · Camden County
First posted
Registry updated
Added to the directory